Literature DB >> 28979678

TUSC7 acts as a tumor suppressor in colorectal cancer.

Weidan Ren1, Shuo Chen2, Guiwei Liu1, Xuesong Wang1, Haopeng Ye1, Yanguo Xi3.   

Abstract

Increasing studies showed that long non-coding RNAs (lncRNAs) played important roles in the development and progression of tumors. Previous evidences suggested that Tumor suppressor candidate 7 (TUSC7) was involved in several tumors initiation. However, the role of TUSC7 in colorectal cancer is still unknown. In this study, we indicated that the expression of TUSC7 was downregulated in colorectal cancer cell lines and tissues. Moreover, the expression of TUSC7 was lower in the high-grade (Dukes C and D) colorectal cancer patients compared to that in the low-grade colorectal cancer patients (Dukes A and B). Colorectal cancer patients with a lower level of TUSC7 expression had worse overall survival rate. Elevated expression of TUSC7 suppressed SW480 and HT29 cell proliferation and invasion. In addition, we demonstrated that overexpression of TUSC7 inhibited the expression of miR-10a and enhanced the expression of PTEN and EphA8, which were the direct target genes of miR-10a. Furthermore, the expression of miR-10a was upregulated in colorectal cancer cell lines and tissues. TUSC7 suppressed colorectal cancer cell proliferation and invasion partly through targeting miR-10a. These results suggested that TUSC7 played as a tumor suppressor gene in colorectal cancer partly through inhibiting miR-10a expression.

Entities:  

Keywords:  Colorectal cancer; LncRNAs; TUSC7; miR-10a

Year:  2017        PMID: 28979678      PMCID: PMC5622247     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  38 in total

1.  The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma.

Authors:  Chuan Jin; Bingchuan Yan; Qin Lu; Yanmin Lin; Lei Ma
Journal:  Tumour Biol       Date:  2015-10-20

2.  MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1).

Authors:  Peng Li; Wan-Jiang Xue; Ying Feng; Qin-Sheng Mao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 3.  MicroRNAs predict and modulate responses to chemotherapy in colorectal cancer.

Authors:  Xin Yu; Zheng Li; Jun Yu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-22       Impact factor: 6.831

4.  The lncRNA MALAT1 protects the endothelium against ox-LDL-induced dysfunction via upregulating the expression of the miR-22-3p target genes CXCR2 and AKT.

Authors:  Yong Tang; Xian Jin; Yin Xiang; Yu Chen; Cheng-xing Shen; Ya-chen Zhang; Yi-gang Li
Journal:  FEBS Lett       Date:  2015-09-10       Impact factor: 4.124

5.  Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer.

Authors:  Bo Liu; Er-Dong Shen; Ming-Mei Liao; Yong-Bin Hu; Kai Wu; Pu Yang; Lin Zhou; Wei-Dong Chen
Journal:  Tumour Biol       Date:  2016-01-26

6.  MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.

Authors:  Binghong Xiong; Yong Cheng; Li Ma; Caiquan Zhang
Journal:  Int J Oncol       Date:  2012-11-20       Impact factor: 5.650

7.  C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.

Authors:  Xiaolu He; Xueming Tan; Xiang Wang; Heiying Jin; Li Liu; Limei Ma; Hong Yu; Zhining Fan
Journal:  Tumour Biol       Date:  2014-09-04

8.  Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge.

Authors:  Liang Deng; Shi-Bin Yang; Feng-Feng Xu; Ji-Hong Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-02-19

9.  Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.

Authors:  M-Z Ma; B-F Chu; Y Zhang; M-Z Weng; Y-Y Qin; W Gong; Z-W Quan
Journal:  Cell Death Dis       Date:  2015-01-08       Impact factor: 8.469

10.  Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma.

Authors:  Yufeng Wang; Zhikui Liu; Bowen Yao; Changwei Dou; Meng Xu; Yumo Xue; Linglong Ding; Yuli Jia; Hongyong Zhang; Qing Li; Kangsheng Tu; Yang Jiao; Qingguang Liu; Cheng Guo
Journal:  Tumour Biol       Date:  2016-03-22
View more
  4 in total

1.  Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p: a population-based case-control study.

Authors:  Qian Yang; Chunhua Song; Peng Wang; Hua Ye; Liping Dai; Jianying Zhang; Kaijuan Wang
Journal:  Int J Clin Oncol       Date:  2021-04-22       Impact factor: 3.402

2.  Long Non-coding RNA LOC285194 Promotes Epithelial Ovarian Cancer Progression via the Apoptosis Signaling Pathway.

Authors:  Ga Won Yim; Dae Woo Lee; Jae In Kim; Young Tae Kim
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

3.  lncRNA TUSC7 inhibits osteosarcoma progression through the miR‑181a/RASSF6 axis.

Authors:  Aiqing Zhao; Wanlin Liu; Xiaolong Cui; Na Wang; Yuxin Wang; Liang Sun; Huiqin Xue; Lishuan Wu; Shuxia Cui; Yun Yang; Rui Bai
Journal:  Int J Mol Med       Date:  2020-12-18       Impact factor: 4.101

4.  Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375.

Authors:  Lulu Wang; Jiankui Jiang; Guisen Sun; Panpan Zhang; Ya Li
Journal:  Oncol Lett       Date:  2020-08-20       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.